11 research outputs found
Supporting energy regulation by monitoring land motion on a regional and national scale: a case study of Scotland
The advent of new satellite and data processing techniques have meant that routine, operational and reliable surveys of land motion on a regional and national scale are now possible. In this paper, we apply a novel satellite remote sensing technique, the Intermittent Small Baseline Subset method, to data from a new satellite mission, Sentinel-1, and demonstrate that a wide area map of ground deformation can be generated that supports the regulation of a range of energy related activities. The area for the demonstration is mainland Scotland (75,000 km2) and the land motion map required the processing of some 627 images acquired from March 2015 to April 2017. The results show that land motion is encountered almost everywhere across Scotland, dominated by subsidence over peatland areas. However, many other phenomena are also encountered including landslides and deformation associated with mining and civil engineering activities. Considering specifically Petroleum Exploration and Development Licence areas offered under the 14th Onshore Licensing Round in the UK, examples of the types of land motion are shown, including an example related to soil restoration by a wind farm. It is demonstrated that, in Scotland at least, almost all licence areas contain deformation of one form or another and, furthermore, the causes of that subsidence are dynamic and likely to be changing from year-to-year. Therefore, maps like this are likely to be of enormous use in a regulatory framework to scope out pre-existing problems in a licence area and to ensure that the correct monitoring framework is put in place once activities begin. They can also provide evidence of good practice and give assurance against litigation by third parties
The effect of lead on the phytochemistry of Tithonia diversifolia exposed to roadside automotive pollution or grown in pots of Pb-supplemented soil
Incorporating Pharmacometrics into Pharmacoeconomic Models: Applications from Drug Development
Chilling-enhanced photooxidation: The production, action and study of reactive oxygen species produced during chilling in the light
American pediatric society’s 2017 John Howland award acceptance lecture: a tale of two toxicants: childhood exposure to lead and tobacco
Tobacco Use and Smoke Exposure in Children: New Trends, Harm, and Strategies to Improve Health Outcomes
Enhanced molecular appreciation of psychiatric disorders through high-dimensionality data acquisition and analytics
Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial
Background Stents are an alternative treatment to carotid endarterectomy for symptomatic carotid stenosis, but previous trials have not established equivalent safety and efficacy. We compared the safety of carotid artery stenting with that of carotid endarterectomy. Methods The International Carotid Stenting Study (ICSS) is a multicentre, international, randomised controlled trial with blinded adjudication of outcomes. Patients with recently symptomatic carotid artery stenosis were randomly assigned in a 1:1 ratio to receive carotid artery stenting or carotid endarterectomy. Randomisation was by telephone call or fax to a central computerised service and was stratified by centre with minimisation for sex, age, contralateral occlusion, and side of the randomised artery. Patients and investigators were not masked to treatment assignment. Patients were followed up by independent clinicians not directly involved in delivering the randomised treatment. The primary outcome measure of the trial is the 3-year rate of fatal or disabling stroke in any territory, which has not been analysed yet. The main outcome measure for the interim safety analysis was the 120-day rate of stroke, death, or procedural myocardial infarction. Analysis was by intention to treat (ITT). This study is registered, number ISRCTN25337470. Findings The trial enrolled 1713 patients (stenting group, n=855; endarterectomy group, n=858). Two patients in the stenting group and one in the endarterectomy group withdrew immediately after randomisation, and were not included in the ITT analysis. Between randomisation and 120 days, there were 34 (Kaplan-Meier estimate 4.0%) events of disabling stroke or death in the stenting group compared with 27 (3.2%) events in the endarterectomy group (hazard ratio [HR] 1.28, 95% CI 0.77-2.11). The incidence of stroke, death, or procedural myocardial infarction was 8.5% in the stenting group compared with 5.2% in the endarterectomy group (72 vs 44 events; HR 1.69, 1.16-2.45, p=0.006), Risks of any stroke (65 vs 35 events; HR 1.92, 1.27-2.89) and all-cause death (19 vs seven events; HR 2.76, 1.16-6.56) were higher in the stenting group than in the endarterectomy group. Three procedural myocardial infarctions were recorded in the stenting group, all of which were fatal, compared with four, all non-fatal, in the endarterectomy group. There was one event of cranial nerve palsy in the stenting group compared with 45 in the endarterectomy group. There were also fewer haematomas of any severity in the stenting group than in the endarterectomy group (31 vs 50 events; p=0.0197). Interpretation Completion of long-term follow-up is needed to establish the efficacy of carotid artery stenting compared with endarterectomy. In the meantime, carotid endarterectomy should remain the treatment of choice for patients suitable for surgery
Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology
Solute carriers form one of three major superfamilies of membrane transporters in humans, and include uniporters, exchangers and symporters. Following several decades of molecular characterisation, multiple solute carriers that form obligatory heteromers with unrelated subunits are emerging as a distinctive principle of membrane transporter assembly. Here we comprehensively review experimentally established heteromeric solute carriers: SLC3-SLC7 amino acid exchangers, SLC16 monocarboxylate/H+ symporters and basigin/embigin, SLC4A1 (AE1) and glycophorin A exchanger, SLC51 heteromer Ost α-Ost β uniporter, and SLC6 heteromeric symporters. The review covers the history of the heteromer discovery, transporter physiology, structure, disease associations and pharmacology - all with a focus on the heteromeric assembly. The cellular locations, requirements for complex formation, and the functional role of dimerization are extensively detailed, including analysis of the first complete heteromer structures, the SLC7-SLC3 family transporters LAT1-4F2hc, b0,+AT-rBAT and the SLC6 family heteromer B0AT1-ACE2. We present a systematic analysis of the structural and functional aspects of heteromeric solute carriers and conclude with common principles of their functional roles and structural architecture